全文获取类型
收费全文 | 6286篇 |
免费 | 583篇 |
国内免费 | 5篇 |
学科分类
医药卫生 | 6874篇 |
出版年
2023年 | 96篇 |
2022年 | 136篇 |
2021年 | 254篇 |
2020年 | 197篇 |
2019年 | 268篇 |
2018年 | 251篇 |
2017年 | 208篇 |
2016年 | 199篇 |
2015年 | 203篇 |
2014年 | 270篇 |
2013年 | 346篇 |
2012年 | 507篇 |
2011年 | 491篇 |
2010年 | 241篇 |
2009年 | 184篇 |
2008年 | 327篇 |
2007年 | 326篇 |
2006年 | 279篇 |
2005年 | 254篇 |
2004年 | 236篇 |
2003年 | 198篇 |
2002年 | 179篇 |
2001年 | 72篇 |
2000年 | 83篇 |
1999年 | 76篇 |
1998年 | 36篇 |
1997年 | 26篇 |
1996年 | 29篇 |
1995年 | 22篇 |
1992年 | 36篇 |
1991年 | 40篇 |
1990年 | 35篇 |
1989年 | 37篇 |
1988年 | 34篇 |
1987年 | 41篇 |
1986年 | 29篇 |
1985年 | 46篇 |
1984年 | 29篇 |
1983年 | 28篇 |
1980年 | 21篇 |
1979年 | 60篇 |
1978年 | 39篇 |
1977年 | 28篇 |
1976年 | 31篇 |
1975年 | 29篇 |
1974年 | 36篇 |
1972年 | 26篇 |
1971年 | 33篇 |
1970年 | 22篇 |
1968年 | 21篇 |
排序方式: 共有6874条查询结果,搜索用时 0 毫秒
61.
ABSTRACTHybrid organizations in modern health movements adopt multiple organizational logistics, allowing them to more effectively achieve social change. We conducted an analysis of 152 probreastfeeding organization websites categorized as institutionalized organizations, grassroots organizations, or hybrid organizations. Through a series of ANOVA analyses, we found that hybrid’s websites provide significantly more useful health care information, better maintained dialogue with members, more efficiently mobilized members, commoditized health care issues less, and created member identity while maintaining institutional ties. Ultimately, hybrids tended to incorporate the positive elements from both grassroots and institutional organizations, while rejecting many of the negative elements. 相似文献
62.
Burgio Francesca Benavides-Varela Silvia Toffano Roberta Palmer Katie Meneghello Francesca Arcara Giorgio Semenza Carlo 《Neurological sciences》2022,43(1):299-303
Neurological Sciences - Patients with mild cognitive impairment (MCI) might experience difficulties in numerical and financial abilities of daily living that compromise their autonomy. The aim of... 相似文献
63.
64.
Vicki L. Davis Firdos Shaikh Katie M. Gallagher Michael Villegas Sheri L. Rea J. Mark Cline Claude L. Hughes 《Hormones & cancer》2012,3(5-6):227-239
The estrogen receptor ?? (ER??) splicing variant with an in-frame deletion of exon 3 (ER??3) is frequently expressed in the normal breast, but its influence on tumorigenesis has not been explored. In vitro, ER??3 has dominant negative activity, suggesting it may suppress estrogen stimulation in the breast. ER??3 may inhibit classical signaling on estrogen response element (ERE)-regulated genes as well as activate non-classical pathways at Sp1 and AP-1 sites. Transgenic mice were developed that express mouse ER??3 in all tissues examined, including the mammary gland. To investigate if ER??3 expression affects tumorigenesis, ER??3 mice were crossbred with MMTV-Neu mice. Mammary tumor onset was significantly delayed in ER??3/Neu versus MMTV-Neu females and metastatic incidence and burden was significantly reduced. Consequently, ER??3 expression suppressed tumor development and metastasis in this aggressive model of HER2/Neu-positive breast cancer. To determine if ER ligands with anticancer activity may augment ER??3 protection, the bitransgenic mice were treated with tamoxifen and soy isoflavones starting at age 2?months. Soy protein with isoflavones (181?mg/1,800?kcal) did not affect tumor development in MMTV-Neu or ER??3/Neu mice; however, metastatic progression was not inhibited in soy-treated ER??3/Neu mice, as it was in untreated ER??3/Neu mice. In contrast, tamoxifen (20?mg/1,800?kcal) significantly enhanced tumor prevention in ER??3/Neu versus MMTV-Neu mice (98?% vs. 81?% tumor free). The results in ER??3/Neu mice demonstrate that ER??3 influences estrogen-dependent mammary carcinogenesis and, thus, may be protective in women expressing ER??3 in the breast. However, exposure to different estrogens may augment or block its beneficial effects. 相似文献
65.
66.
67.
68.
Lisa K. Ryan Katie B. Freeman Jorge A. Masso-Silva Klaudia Falkovsky Ashwag Aloyouny Kenneth Markowitz Amy G. Hise Mahnaz Fatahzadeh Richard W. Scott Gill Diamond 《Antimicrobial agents and chemotherapy》2014,58(7):3820-3827
There is a strong need for new broadly active antifungal agents for the treatment of oral candidiasis that not only are active against many species of Candida, including drug-resistant strains, but also evade microbial countermeasures which may lead to resistance. Host defense peptides (HDPs) can provide a foundation for the development of such agents. Toward this end, we have developed fully synthetic, small-molecule, nonpeptide mimetics of the HDPs that improve safety and other pharmaceutical properties. Here we describe the identification of several HDP mimetics that are broadly active against C. albicans and other species of Candida, rapidly fungicidal, and active against yeast and hyphal cultures and that exhibit low cytotoxicity for mammalian cells. Importantly, specificity for Candida over commensal bacteria was also evident, thereby minimizing potential damage to the endogenous microbiome which otherwise could favor fungal overgrowth. Three compounds were tested as topical agents in two different mouse models of oral candidiasis and were found to be highly active. Following single-dose administrations, total Candida burdens in tongues of infected animals were reduced up to three logs. These studies highlight the potential of HDP mimetics as a new tool in the antifungal arsenal for the treatment of oral candidiasis. 相似文献
69.
70.